)
Visual
test
SyntheticMR
SyntheticMR (SYNT) investor relations material
SyntheticMR Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary28 Nov, 2025
Executive summary
Net sales for Q3 2025 were SEK 12.4 million, down 7% year-over-year, with APAC as the main negative contributor and other regions showing slight growth.
Operating profit for Q3 was -SEK 25.1 million, including a SEK 18.5 million impairment, mainly related to contract assets in India.
Net profit for Q3 was -SEK 25.2 million, and earnings per share before dilution were -0.43 SEK.
The acquisition of Combinostics was completed in January 2025, strengthening the product portfolio and recurring revenue base.
Regulatory approvals for SyMRI 15 (3D) were obtained in South Korea, Japan, and India during 2025.
Financial highlights
Q3 net sales: SEK 12.4 million (down 7% year-over-year); first nine months: SEK 39.1 million (down 9%).
Q3 operating profit: -SEK 25.1 million; adjusted operating profit: -SEK 6.6 million (excluding impairment).
Q3 net profit: -SEK 25.2 million; first nine months: -SEK 48.9 million.
Cash flow from operating activities in Q3: -SEK 3.0 million; cash and cash equivalents at period end: SEK 13.3 million.
ARR from cNeuro increased 35% year-to-date, reaching SEK 11.5 million.
Outlook and guidance
Order intake at the start of Q4 is strong, with expectations to return to growth in Q4 2025.
Business models are shifting toward more recurring revenue and front-loaded cash flows.
Focus areas include expanding ARR, strengthening sales execution, and deepening OEM partnerships.
FDA decision on Combinostics' ARIA application expected in H1 2026.
Impact of legacy SyMRI model on contract assets
Combinostics FDA and SyMRI 3D exclusivity impact
Cash flow strategy for 2026 and beyond
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 443060
Operating profit rose 28.9% in 2025, with strong core business and digital segment growth. - GM
Disciplined transformation, resilient cash flow, and software growth drive a strong outlook. - BTBT
Transitioned to a strategic asset model centered on ETH staking and AI infrastructure growth. - COR
Q1 FY2026 revenue up 5.5% to $85.9B; adjusted EPS rose 9.4% to $4.08. - STC
Scalable, high-margin IT communications provider for SMBs with strong recurring revenue and growth momentum. - APAM
AUM hit $180B, strong returns and Grandview deal drove growth despite equity outflows. - PSX
Q4 2025 earnings hit $2.9B, with record refining yields and strong portfolio transformation. - ARCC
FY 2025 delivered $2.01 Core EPS, $1.86 net income/share, and a $0.48 Q1 2026 dividend. - HMN
Record core earnings, 12.4% ROE, and 10% EPS growth guidance for 2026. - AFG
Record underwriting profit, strong ROE, and over $700M returned to shareholders in 2025.
Next SyntheticMR earnings date
Q4 20256 Feb, 2026
SyntheticMR
Next SyntheticMR earnings date
Q4 20256 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
SyntheticMR's innovative software products for MRI shorten exam times and enable more information to be extracted from the images. These benefits create a better patient experience, reducing the time spent in the noisy, claustrophobic bore of the scanner. The company's customers across the globe are realizing cost savings in both their daily clinical workflow, as well as their yearly budgets. SyntheticMR's products manage a wide variety of exams such as Cardiac MRI, Breast MRI and Body MRI, with applications in Cardiology, Neurosurgery and Oncology.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage